Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan A. Dyckerhoff Sells 197,297 Shares

Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan A. Dyckerhoff sold 197,297 shares of the company’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $90.51, for a total value of $17,857,351.47. Following the completion of the transaction, the director now owns 6,148 shares of the company’s stock, valued at $556,455.48. The trade was a 96.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Astera Labs Stock Performance

Shares of ALAB stock opened at $103.93 on Friday. Astera Labs, Inc. has a 52 week low of $36.22 and a 52 week high of $108.37. The stock’s fifty day moving average is $68.42 and its 200-day moving average is $59.80.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.06. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The firm had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. The business’s quarterly revenue was up 47.1% on a year-over-year basis. As a group, analysts predict that Astera Labs, Inc. will post -0.45 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in ALAB. Hollencrest Capital Management acquired a new stake in shares of Astera Labs during the 3rd quarter worth approximately $26,000. US Bancorp DE acquired a new stake in Astera Labs during the 3rd quarter worth $46,000. First Horizon Advisors Inc. bought a new stake in shares of Astera Labs during the 3rd quarter valued at $49,000. Allworth Financial LP lifted its stake in shares of Astera Labs by 445.5% in the 3rd quarter. Allworth Financial LP now owns 1,091 shares of the company’s stock valued at $57,000 after purchasing an additional 891 shares during the period. Finally, Amalgamated Bank bought a new position in shares of Astera Labs in the 2nd quarter worth $74,000.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on ALAB shares. Craig Hallum increased their price objective on shares of Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Morgan Stanley upped their price objective on Astera Labs from $74.00 to $94.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Roth Mkm raised their target price on Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Finally, JPMorgan Chase & Co. upped their price target on Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Astera Labs presently has an average rating of “Buy” and a consensus target price of $94.67.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.